Dose-Dependent Von Willebrand Factor Inhibition by Aptamer BB-031 Correlates with Thrombolysis in a Microfluidic Model of Arterial Occlusion

Susan M. Shea(University of Pittsburgh), Shahid M. Nimjee(The Ohio State University), Emily Mihalko(University of Iowa), Bruce A. Sullenger(Duke University), Christina Daniel(Washington University in St. Louis), Kimberly A. Thomas(Washington University in St. Louis), Rassam M. G. Rassam(University of Pittsburgh), Philip C. Spinella(University of Pittsburgh)
Pharmaceuticals
November 22, 2022
Cited by 13


Related Papers